Главная Назад


Авторизация
Идентификатор пользователя / читателя
Пароль (для удалённых пользователей)
 

Вид поиска

Область поиска
в найденном
Найдено в других БД
Формат представления найденных документов:
библиографическое описание краткийполный
Отсортировать найденные документы по:
авторузаглавиюгоду изданиятипу документа
Поисковый запрос: (<.>S=ОТВЕТ НА ЛЕЧЕНИЕ<.>)
Общее количество найденных документов : 70
Показаны документы с 1 по 20
 1-20    21-40   41-60   61-70 
1.
Serum hepatitis C virus RNA levels in chronic hepatitis C - importance for outcome of interferon alfa-2b treatment // Scand. J. Infec. Diseases, 1994. Vol. 26, N 3.-С.263- 270

2.
Serum interleukin-6 (IL-6) and interleukin-4 (IL-4) in patients with multiple myeloma (MM) // Brit. J. Haematol., 1996. Vol. 92, N 2.-С.420-422

3.
Serum interleukin-6 (IL-6) and interleukin-4 (IL-4) in patients with multiple myeloma (MM) // Brit. J. Haematol., 1996. Vol. 92, N 2.-С.420-422

4.
Serum interleukin-6 (IL-6) and interleukin-4 (IL-4) in patients with multiple myeloma (MM) // Brit. J. Haematol., 1996. Vol. 92, N 2.-С.420-422

5.
Wennerberg Predicting response to therapy of squamous cell carcinoma of the head and neck (Review) // Anticancer Res., 1996. Vol. 16, N 4.-С.2389-2396

6.
Prognostic and predictive relevance of c--erbB-2 and ras expression in node positive and negative breast cancer // Anticancer Res., 1994. Vol. 14, N 3b.-С.1441-1450

7.
Prognostic and predictive relevance of c--erbB-2 and ras expression in node positive and negative breast cancer // Anticancer Res., 1994. Vol. 14, N 3b.-С.1441-1450

8.
High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukemia at diagnosis // Blood, 1996. Vol. 87, N 3.-С.1155-1161

9.
High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukemia at diagnosis // Blood, 1996. Vol. 87, N 3.-С.1155-1161

10.
Prognostic and predictive relevance of c--erbB-2 and ras expression in node positive and negative breast cancer // Anticancer Res., 1994. Vol. 14, N 3b.-С.1441-1450

11.
High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukemia at diagnosis // Blood, 1996. Vol. 87, N 3.-С.1155-1161

12.
FGF8 mRNA expression in benign and malignant prostate relationship to androgen receptor status // J. Pathol., 1997. Vol. 181, Suppl..-С.35

13.
Combined progesterone and oestrogen receptor (PR and ER) status in predicting hormone sensitive breast cancer: Better than ER alone? // J. Pathol., 1997. Vol. 181, Suppl..-С.5

14.
FGF8 mRNA expression in benign and malignant prostate relationship to androgen receptor status // J. Pathol., 1997. Vol. 181, Suppl..-С.35

15.
FGF8 mRNA expression in benign and malignant prostate relationship to androgen receptor status // J. Pathol., 1997. Vol. 181, Suppl..-С.35

16.
Combined progesterone and oestrogen receptor (PR and ER) status in predicting hormone sensitive breast cancer: Better than ER alone? // J. Pathol., 1997. Vol. 181, Suppl..-С.5

17.
FGF8 mRNA expression in benign and malignant prostate relationship to androgen receptor status // J. Pathol., 1997. Vol. 181, Suppl..-С.35

18.
Combined progesterone and oestrogen receptor (PR and ER) status in predicting hormone sensitive breast cancer: Better than ER alone? // J. Pathol., 1997. Vol. 181, Suppl..-С.5

19.
Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment // Nature Genet., 1999. Vol. 22, N 2.-С.168-170

20.
van Dalen A. TPS monitoring in metastatic breast cancer // Int. J. Biol. Markers, 1999. Vol. 14, N 1.-С.45-48

 1-20    21-40   41-60   61-70 
 




© Международная Ассоциация пользователей и разработчиков электронных библиотек и новых информационных технологий
(Ассоциация ЭБНИТ)